12 Oct 2025 | 5 Mins Read
Sandeep Tandon of Quant MF sees generic pharma as a compelling trade
Flipitmoney
The Indian pharmaceutical sector gained 2% last week, outperforming the Nifty benchmark, as the US administration dropped tariff plans on goods deemed a potential threat to national security, easing concerns for Indian drug manufacturers, and a new US Biosecure Act version benefits Indian contract development and manufacturing organisations (CDMOs).